Skip to Content

cefazolin FDA Alerts

The FDA Alert(s) below may be specifically about cefazolin or relate to a group or class of drugs which include cefazolin.

MedWatch Safety Alerts are distributed by the FDA and published by Following is a list of possible medication recalls, market withdrawals, alerts and warnings. For the latest FDA MedWatch alerts, go here.

Recent FDA Alert(s) for cefazolin

Cefazolin for Injection

Mar 1, 2006

Audience: Healthcare professionals and hosptal risk managers

[Posted 03/01/2006] Hanford Pharmaceuticals and FDA notified healthcare professionals about the recall of four lots (379,975 vials) of Cefazolin for Injection, USP, 1 g/10 mL vials, an antibiotic used in a hospital environment to treat skin and skin structure, respiratory and other infections.The product was distributed by Sandoz, Inc. of Broomfield, CO and Watson Pharmaceuticals, Inc. of Corona, CA. Certain lots of the active ingredient used to manufacture the product have been shown to contain microbial contamination (Bacillus pumilus, Staphylococcus hominis, Propionibacterium acnes, or Micrococcus luteus) which may pose a serious or life-threatening risk for some patients.  Hospitals, clinics, and users should stop using the affected lots immediately.

[February 2006 – Press Release –G.C. Hanford Manufacturing Co.]

More cefazolin Resources